LAURA EIDEM
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Physician Assistant
- Where
- HORICON, WI
- NPI
- 1083382204
- Received
- $10,931 in 481 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 134 | $2,709 |
| 2024 | General payment | 104 | $2,586 |
| 2023 | General payment | 162 | $3,416 |
| 2022 | General payment | 80 | $2,189 |
| 2021 | General payment | 1 | $29 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 126 | $2,192 | 2022–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 79 | $1,285 | 2022–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $1,153 | 2022–2025 |
| Otsuka America Pharmaceutical, Inc. | 37 | $767 | 2022–2025 |
| Janssen Pharmaceuticals, Inc | 20 | $583 | 2022–2025 |
| Neurocrine BioSciences, Inc. | 21 | $561 | 2023–2025 |
| Axsome Therapeutics, Inc. | 15 | $526 | 2023–2025 |
| Alkermes, Inc. | 15 | $492 | 2022–2025 |
| Supernus Pharmaceuticals, Inc. | 9 | $441 | 2023–2025 |
| Corium, LLC | 22 | $421 | 2022–2025 |
| Tris Pharma Inc | 14 | $407 | 2023–2024 |
| Teva Pharmaceuticals USA, Inc. | 14 | $395 | 2022–2025 |
| IRONSHORE PHARMACEUTICALS INC. | 13 | $364 | 2022–2024 |
| Lundbeck LLC | 15 | $349 | 2021–2025 |
| Vanda Pharmaceuticals Inc. | 13 | $278 | 2022–2025 |
| IDORSIA PHARMACEUTICALS US INC | 6 | $214 | 2022–2024 |
| Noven Therapeutics, LLC | 9 | $163 | 2022–2024 |
| E.R. Squibb & Sons, L.L.C. | 7 | $148 | 2024–2025 |
| Neos Therapeutics, LP | 5 | $100 | 2023–2024 |
| Collegium Pharmaceutical, Inc. | 2 | $38 | 2025 |
| Merck Sharp & Dohme LLC | 1 | $18 | 2023 |
| Almatica Pharma LLC | 1 | $14 | 2025 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 481 | $10,931 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-17 | Takeda Pharmaceuticals U.S.A., Inc. | $10 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-12-16 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-10 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-09 | Janssen Pharmaceuticals, Inc | $28 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-12-03 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-12-03 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-03 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-12 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-11 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-04 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-04 | Vanda Pharmaceuticals Inc. | $12 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-29 | Neurocrine BioSciences, Inc. | $32 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-29 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | Takeda Pharmaceuticals U.S.A., Inc. | $12 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-10-08 | Vanda Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-08 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-08 | Takeda Pharmaceuticals U.S.A., Inc. | $8 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-01 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-24 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | Janssen Pharmaceuticals, Inc | $23 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-09-17 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-10 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-10 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-09-03 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-03 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-02 | Collegium Pharmaceutical, Inc. | $23 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-20 | Neurocrine BioSciences, Inc. | $33 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-20 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-13 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-06 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-31 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-30 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-30 | Takeda Pharmaceuticals U.S.A., Inc. | $8 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-23 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-23 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-22 | Collegium Pharmaceutical, Inc. | $14 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-07-16 | Takeda Pharmaceuticals U.S.A., Inc. | $25 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-07-16 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-16 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-15 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-24 | Neurocrine BioSciences, Inc. | $91 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-24 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-19 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-06-18 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-18 | Takeda Pharmaceuticals U.S.A., Inc. | $10 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-06-11 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-11 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-28 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-27 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-22 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-21 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-20 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-14 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-14 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-07 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-05-07 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-06 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-30 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-29 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-23 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-23 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-23 | Takeda Pharmaceuticals U.S.A., Inc. | $8 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-04-22 | Axsome Therapeutics, Inc. | $30 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-16 | Corium, LLC | $19 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2025 | |
| 2025-04-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-16 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-09 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-04-09 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-09 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-08 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-08 | Otsuka America Pharmaceutical, Inc. | $1 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-02 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-04-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-01 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-03-26 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-26 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-25 | Alkermes, Inc. | $34 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-19 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-03-19 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-18 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-03-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-12 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-12 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-05 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-26 | Lundbeck LLC | $27 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-26 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-26 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-25 | ABBVIE INC. | $123 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-11 | Supernus Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-02-11 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-05 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-02-05 | Almatica Pharma LLC | $14 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-02-05 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-04 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-04 | Vanda Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-01-30 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-29 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-29 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-29 | Otsuka America Pharmaceutical, Inc. | $2 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-28 | Vanda Pharmaceuticals Inc. | $32 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-01-21 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-01-15 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-15 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-14 | Vanda Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-01-08 | Janssen Pharmaceuticals, Inc | $32 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-01-08 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-01-08 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-18 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-12-18 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-11 | Lundbeck LLC | $31 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-12-11 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-12-11 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-04 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-12-04 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-04 | Takeda Pharmaceuticals U.S.A., Inc. | $4 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-11-27 | Noven Therapeutics, LLC | $19 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-11-20 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-20 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-11-19 | Axsome Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-11-19 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-13 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-06 | IRONSHORE PHARMACEUTICALS INC. | $25 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-11-06 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-11-06 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-30 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-10-30 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-23 | Noven Therapeutics, LLC | $22 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-10-23 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-16 | Corium, LLC | $32 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-10-15 | Vanda Pharmaceuticals Inc. | $30 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-10-09 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-10-07 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-10-02 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-02 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-18 | Lundbeck LLC | $33 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-18 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-18 | Corium, LLC | $9 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-09-17 | IRONSHORE PHARMACEUTICALS INC. | $21 | Food and Beverage | In-kind items and services | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-09-11 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-09-11 | Takeda Pharmaceuticals U.S.A., Inc. | $0 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-09-04 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-09-04 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-08-28 | Corium, LLC | $23 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-08-28 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | Takeda Pharmaceuticals U.S.A., Inc. | $6 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-08-20 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-01 | Noven Therapeutics, LLC | $18 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-07-31 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-17 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-07-10 | Lundbeck LLC | $31 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-04 | Corium, LLC | $25 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-07-03 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-25 | Takeda Pharmaceuticals U.S.A., Inc. | $16 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-06-18 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-14 | Noven Therapeutics, LLC | $18 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-06-11 | Corium, LLC | $24 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-06-04 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-05-29 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-05-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $107 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-22 | Lundbeck LLC | $29 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-22 | Neos Therapeutics, LP | $17 | Food and Beverage | Cash or cash equivalent | Adzenys XR-ODT Drug, ADHD | 2024 | |
| 2024-05-22 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-15 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-05-15 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-15 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-05-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-08 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-03 | Supernus Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-05-02 | Noven Therapeutics, LLC | $18 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-05-01 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 |
The latest 200 records of 481.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Horicon, WI, county Dodge County, WI, state Wisconsin; placed by its city name.
| Measure | Place (city or town) Horicon, WI | County Dodge County, WI | State Wisconsin |
|---|---|---|---|
| Population B01003 | 3,814 | 88,742 | 5,914,872 |
| Population, 2020 census P1 | 3,767 | 89,396 | 5,893,718 |
| Median age B01002 | 39.3 | 43.0 | 40.2 |
| Under 18 B01001 | 23.3% | 19.4% | 21.4% |
| 65 and over B01001 | 17.6% | 19.0% | 18.5% |
| Households B11001 | 1,862 | 35,910 | 2,479,480 |
| Foreign born B05002 | 0.4% | 2.4% | 5.2% |
| Median household income B19013 | $53,465 | $75,929 | $77,485 |
| Median family income B19113 | $73,158 | $94,523 | $100,141 |
| Per capita income B19301 | $34,164 | $38,304 | $43,373 |
| Poverty rate B17001 | 14.1% | 8.5% | 10.6% |
| Unemployment rate B23025 | 4.8% | 3.8% | 3.2% |
| Civilian labor force B23025 | 2,023 | 47,071 | 3,132,770 |
| Mean commute (minutes) B08013 | 21.0 | 24.1 | 22.2 |
| Bachelor's degree or higher B15003 | 17.9% | 20.3% | 33.4% |
| Housing units B25001 | 1,918 | 38,524 | 2,778,572 |
| Owner-occupied B25003 | 66.1% | 71.3% | 67.8% |
| Renters B25003 | 33.9% | 28.7% | 32.2% |
| Median home value B25077 | $172,500 | $231,900 | $266,500 |
| Median gross rent B25064 | $906 | $988 | $1,087 |
| White, not Hispanic B03002 | 90.2% | 87.3% | 78.6% |
| Black B03002 | 0.2% | 2.5% | 5.9% |
| Hispanic or Latino B03002 | 2.6% | 6.7% | 8.0% |
| Asian B03002 | 0.0% | 0.5% | 2.9% |
| American Indian and Alaska Native B03002 | 0.0% | 0.3% | 0.5% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Horicon, WI.
Comments